Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma

Journal of Glaucoma

Volumn 20, Issue 3, 2011, Pages 196-201

  Takihara, Yuji ^a,b   Inatani, Masaru ^a   Kawaji, Takahiro ^a   Fukushima, Mikiko ^a   Iwao, Keiichiro ^a   Iwao, Minako ^a   Tanihara, Hidenobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

comparative study; intravitreal bevacizumab; neovascular glaucoma; trabeculectomy

Indexed keywords

BEVACIZUMAB; MITOMYCIN C;

ADULT; AGED; ARTICLE; CHOROID DETACHMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOPHTHALMITIS; ENUCLEATION; FEMALE; FOLLOW UP; HUMAN; HYPHEMA; HYPOTONY MACULOPATHY; INTERMETHOD COMPARISON; INTRAOCULAR PRESSURE; KAPLAN MEIER METHOD; MALE; MENTAL DETERIORATION; NEOVASCULAR GLAUCOMA; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME; TRABECULECTOMY; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; ALKYLATING AGENTS; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; FEMALE; GLAUCOMA, NEOVASCULAR; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; MITOMYCIN; RETROSPECTIVE STUDIES; TRABECULECTOMY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 80755137323     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e3181d9ce12     Document Type: Article

References (26)

1. Sivak-Callcott JA, O'Day DM, Gass JD, et al. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. 2001;108:1767-1778.
2. Brown GC, Magargal LE, Schachat A, et al. Neovascular glaucoma. Etiologic considerations. Ophthalmology. 1984;91:315-320.
3. Hayreh SS. Neovascular glaucoma. Prog Retin Eye Res. 2007;26:470-485. (Pubitemid 47304464)
4. Kiuchi Y, Sugimoto R, Nakae K, et al. Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients. Ophthalmologica. 2006;220:383-388. (Pubitemid 44725975)
5. Tsai JC, Feuer WJ, Parrish RK II, et al. 5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study. Ophthalmology. 1995;102:887-892.
6. Every SG, Molteno AC, Bevin TH, et al. Long-term results of Molteno implant insertion in cases of neovascular glaucoma. Arch Ophthalmol. 2006;124:355-360.
7. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487. (Pubitemid 24356306)
8. Nissen NN, Polverini PJ, Koch AE, et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol. 1998;152:1445-1452. (Pubitemid 28275003)
9. Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina. 2006;26:275-278. (Pubitemid 44318179)
10. Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina. 2006;26:279-284. (Pubitemid 44318180)
11. Rich RM, Rosenfeld PJ, Puliafito CA, et al. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina. 2006;26:495-511. (Pubitemid 44620390)
12. Yazdani S, Hendi K, Pakravan M. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. J Glaucoma. 2007;16:437-439. (Pubitemid 47263045)
13. Silva Paula J, Jorge R, Alves Costa R, et al. Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma. Acta Ophthalmol Scand. 2006;84:556-557. (Pubitemid 44102857)
14. Iliev ME, Domig D, Wolf-Schnurrbursch U, et al. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol. 2006;142:1054-1056. (Pubitemid 44853889)
15. Wakabayashi T, Oshima Y, Sakaguchi H, et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology. 2008;115:1571-1580.
16. Moraczewski AL, Lee RK, Palmberg PF, et al. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. Br J Ophthalmol. 2009;93:589-593.
17. Kitnarong N, Chindasub P, Metheetrairut A. Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma. Adv Ther. 2008;25:438-443.
18. Cornish KS, Ramamurthi S, Saidkasimova S, et al. Intravitreal bevacizumab and augmented trabeculectomy for neovascular glaucoma in young diabetic patients. Eye. 2009;23:979-981.
19. Jonas JB, Spandau UH, Schlichtenbrede F. Intravitreal bevacizumab for filtering surgery. Ophthalmic Res. 2007;39:121-122. (Pubitemid 46909871)
20. Fakhraie G, Katz LJ, Prasad A, et al. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma. J Glaucoma. 2010. In press.
21. Sidoti PA, Dunphy TR, Baerveldt G, et al. Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma. Ophthalmology. 1995;102:1107-1118.
22. Scappaticci FA, Fehrenbacher L, Cartwright T, et al. Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. J Surg Oncol. 2005;91:173-180. (Pubitemid 41254420)
23. Grewal DS, Jain R, Kumar H, et al. Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study. Ophthalmology. 2008;115:2141-2145.
24. Bakri SJ, Snyder MR, Reid JM, et al. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology. 2007;114:855-859. (Pubitemid 46635858)
25. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432-1444. (Pubitemid 44511558)
26. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419-1431. (Pubitemid 44511557)